Literature DB >> 8526601

Perfadex is superior to Euro-Collins solution regarding 24-hour preservation of vascular function.

R Ingemansson1, G Massa, R K Pandita, T Sjöberg, S Steen.   

Abstract

BACKGROUND: The aim of this study was to compare Perfadex with Euro-Collins solution regarding 24-hour preservation of endothelium-dependent relaxation and vascular smooth muscle function.
METHODS: The infrarenal aorta of 72 isogenic rats was studied in organ baths as fresh controls, after 24 hours of cold (4 degrees C) storage, and after 24-hour storage followed by transplantation and examination after 7 or 30 days. The thromboxane A2 analogue U-46619 was used to test contractility. Acetylcholine chloride was used to elicit endothelium-dependent relaxation and papaverine hydrochloride, to elicit endothelium-independent relaxation.
RESULTS: With both solutions, all grafts were patent after 7 and 30 days. Vessels preserved in Euro-Collins solution for 24 hours lost 95% (p < 0.001) of their contractility compared with fresh controls; 7 days after transplantation, they had regained 40% of initial contractility, and after 30 days, there was no significant decrease in contractility. Vessels preserved in Perfadex manifested no significant decrease in contractility at any time. Endothelium-dependent relaxation could not be evaluated in vessels stored for 24 hours in Euro-Collins solution because they had lost almost all contractility; 7 days after transplantation, endothelium-dependent relaxation was reduced by 65% (p < 0.001), but at 30 days after transplantation, there was no significant decrease in endothelium-dependent relaxation. Vessels preserved in Perfadex for 24 hours lost 17% (p < 0.05) of endothelium-dependent relaxation, but 7 and 30 days after transplantation, there was no significant decrease in endothelium-dependent relaxation.
CONCLUSIONS: Perfadex, but not Euro-Collins solution, has the capacity to preserve vascular function after 24 hours of storage followed by in vivo reperfusion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526601     DOI: 10.1016/0003-4975(95)00548-Y

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease.

Authors:  Yifei Chen; Fuji Yang; Ying Chu; Zhihua Yun; Yongmin Yan; Jianhua Jin
Journal:  J Transl Med       Date:  2022-10-22       Impact factor: 8.440

Review 2.  Challenges in Promoting Mitochondrial Transplantation Therapy.

Authors:  Yuma Yamada; Momo Ito; Manae Arai; Mitsue Hibino; Takao Tsujioka; Hideyoshi Harashima
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

3.  Evaluation of Early Markers of Ischemia-reperfusion Injury and Preservation Solutions in a Modified Hindlimb Model of Vascularized Composite Allotransplantation.

Authors:  Sara Rostami; Michael Xu; Shaishav Datta; Siba Haykal
Journal:  Transplant Direct       Date:  2021-12-13

Review 4.  Hemoglobin-Based Oxygen Carriers: Potential Applications in Solid Organ Preservation.

Authors:  Min Cao; Guoqing Wang; Hongli He; Ruiming Yue; Yong Zhao; Lingai Pan; Weiwei Huang; Yang Guo; Tao Yin; Lina Ma; Dingding Zhang; Xiaobo Huang
Journal:  Front Pharmacol       Date:  2021-11-30       Impact factor: 5.810

5.  Donor lung preservation for transplantation-where do we go from here?

Authors:  Dirk Van Raemdonck; Jan Van Slambrouck; Laurens J Ceulemans
Journal:  J Thorac Dis       Date:  2022-09       Impact factor: 3.005

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.